BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2020 1:54:39 AM | Browse: 720 | Download: 1401
 |
Received |
|
2019-09-02 10:03 |
 |
Peer-Review Started |
|
2019-09-02 10:03 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2019-11-13 07:14 |
 |
Revised |
|
2019-11-18 13:13 |
 |
Second Decision |
|
2019-11-29 09:01 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2019-11-30 03:38 |
 |
Articles in Press |
|
2019-11-30 03:38 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2019-12-12 06:58 |
 |
Typeset the Manuscript |
|
2020-01-02 08:46 |
 |
Publish the Manuscript Online |
|
2020-01-07 01:54 |
Category |
Critical Care Medicine |
Manuscript Type |
Case Report |
Article Title |
Value of dynamic plasma cell-free DNA monitoring on septic shock syndrome: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jing-Ping Liu, Shi-Chang Zhang and Shi-Yang Pan |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
81672100 |
National Natural Science Foundation of China |
81671836 |
the Key Laboratory for Laboratory Medicine of Jiangsu Province of China |
ZDXKB2016005 |
|
Corresponding Author |
Shi-Yang Pan, PhD, Professor, Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Guangzhou Road No. 300, Nanjing 210029, Jiangsu Province, China. sypan@njmu.edu.cn |
Key Words |
Septic shock; Acinetobacter baumannii; Cell-free DNA; Case report; ; |
Core Tip |
The mortality of septic shock is relatively high. Several biomarkers have been evaluated for predicting mortality in patients with septic shock, but none have been shown to be entirely useful in clinical applications. Herein, we report a typical case and review the literature. This case might contribute to improving our understanding of cell-free DNA (cfDNA) in monitoring disease progression during septic shock. This report also suggests that cfDNA could be used to more effectively monitor disease progression than PCT and other inflammatory factors. |
Publish Date |
2020-01-07 01:54 |
Citation |
Liu JP, Zhang SC, Pan SY. Value of dynamic plasma cell-free DNA monitoring on septic shock syndrome: A case report. World J Clin Cases 2020; 8(1): 200-207 |
URL |
https://www.wjgnet.com/2307-8960/full/v8/i1/200.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v8.i1.200 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345